Add Reply
Add Comment As A Guest
Close Topic OptionsAnalysis: GSK bolsters medicine chest with biotechnology buy
Analysis Gsk Bolsters Medicine Chest Biotechnology - Psychology, Special Needs, Health - Posted: 18th Jul, 2012 - 12:30am
Posts: 1 - Views: 309
Biotechnology News
Post Date: 18th Jul, 2012 - 12:30am / Post ID: #
NOTE: Informer [?]
Analysis: GSK bolsters medicine chest with biotechnology buy
Analysis: GSK bolsters medicine chest with biotechnology buy
Biotechnology News
LONDON (Reuters) - GlaxoSmithKline chief executive Andrew Witty has an eye for a bargain. Despite paying a 99 percent premium for Human Genome Sciences, he is still getting the biotechnology company for less than half what it was worth 14 months ago. In exchange for his $3 billion cheque, which GSK can pay out of existing cash resources, Witty gets full control of a clutch of new medicines finally starting to flow from the decoding of human DNA. ...
Source: BioTech News Headlines - Yahoo! News
Sponsored Links:
TOPIC: Analysis: GSK bolsters medicine chest with biotechnology buy